Cytori Cell Research Institute, Inc.

Tokyo Stock Exchange:3750.T

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

🩺 Medical Instruments

Location

Japan

Market Cap

USD 46.67 M

Share Price

USD 5.23

Avg Daily Volume

29,596

Change (1 day)

0.83%

Change (1 year)

Change (YTD)

-5.16%

Cytori Cell Research Institute, Inc. Dividend Yield on June 26, 2025: 0.00%

Cytori Cell Research Institute, Inc. Dividend Yield is 0.00% on June 26, 2025. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Cytori Cell Research Institute, Inc. 52-week low Dividend Yield is 0.00% on June 26, 2025, which is NA below the current Dividend Yield.
Cytori Cell Research Institute, Inc. 52-week low Dividend Yield is 0.00% on June 26, 2025, which is NA below the current Dividend Yield.
Cytori Cell Research Institute, Inc. average Dividend Yield for the last 52 weeks is 0.00%.

Daily

From:

To:

Zoom:

Key data

Date	Dividend Yield	Market Capitalization	Share Price	Share Price

Tokyo Stock Exchange: 3750.T

Cytori Cell Research Institute, Inc.

CEO	Mr. Yoshihiro Hoshino
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	Otemachi Park Building, 1-1-1 Otemachi
Employees	16
Sector	🏥 Health Care
Industries Biotechnology 🔬 Clinical Trials 🏥 Hospitals & Clinics 🩺 Medical Instruments

Description

Cytori Cell Research Institute, Inc., engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. Its products pipeline includes ECCI-50 for the treatment of male stress urinary incontinence and liver cirrhosis; and Cyt-006 to prevent postoperative adhesion for primary rectal cancer. The company is also conducting clinical trials/research on cell therapy for a range of diseases and applications, including anterior cruciate ligament repair, bone repair, burn scars, chronic wound healing, critical limb ischemia, anal and Crohn's disease fistulas, erectile dysfunction, etc. It also invests in, owns, develops, leases, and manages real estate projects and hotels; and provides real estate brokerage services. The company was formerly known as FRACTALE Corporation. Cytori Cell Research Institute, Inc. was incorporated in 2004 and is headquartered in Tokyo, Japan.

Similar companies

MRK

Merck & Co., Inc.

USD 79.67

-0.81%

SHL.DE

Siemens Healthineers AG

USD 54.76

0.58%

207940.KS

Samsung Biologics Co.,Ltd.

USD 738.76

0.66%

BIM.PA

bioMérieux S.A.

USD 139.32

-0.41%

BAX

Baxter International Inc.

USD 30.61

0.07%

RGC

Regencell Bioscience Holdings Limited

USD 21.73

-5.32%

2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.07

-0.24%

CTEC.L

ConvaTec Group Plc

USD 3.96

0.77%

GMED

Globus Medical, Inc.

USD 58.19

-0.80%

002653.SZ

Haisco Pharmaceutical Group Co., Ltd.

USD 5.93

-1.27%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.00

0.06%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-5.44%

688617.SS

APT Medical Inc.

USD 41.26

1.54%

600161.SS

Beijing Tiantan Biological Products Co., Ltd.

USD 2.69

0.37%

TMDX

TransMedics Group, Inc.

USD 128.58

-3.06%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.93

1.22%

000739.SZ

Apeloa Pharmaceutical Co.,Ltd

USD 1.95

-0.78%

JUBLPHARMA.NS

Jubilant Pharmova Limited

USD 13.94

1.28%

0853.HK

MicroPort Scientific Corporation

USD 1.09

1.19%

600420.SS

Shanghai Shyndec Pharmaceutical Co., Ltd.

USD 1.49

0.31%

QDEL

QuidelOrtho Corporation

USD 28.11

-1.95%

NVCR

NovoCure Limited

USD 17.32

1.91%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.99

0.81%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.68

0.72%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.52

-0.59%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.29

-0.52%

ABBV

AbbVie Inc.

USD 185.39

-0.09%

NOVO-B.CO

Novo Nordisk A/S

USD 67.81

-3.56%

RO.SW

Roche Holding AG

USD 341.12

-1.04%

ABT

Abbott Laboratories

USD 137.40

-0.49%

NOVN.SW

Novartis AG

USD 117.76

-0.47%

AZN.L

AstraZeneca PLC

USD 140.14

-0.36%

BSX

Boston Scientific Corporation

USD 104.29

0.16%

TMO

Thermo Fisher Scientific Inc.

USD 410.65

1.55%

AMGN

Amgen Inc.

USD 280.35

1.03%

PFE

Pfizer Inc.

USD 24.26

-0.21%

GILD

Gilead Sciences, Inc.

USD 105.93

-1.19%

SAN.PA

Sanofi

USD 95.90

-1.25%

VRTX

Vertex Pharmaceuticals Incorporated

USD 445.82

-0.99%

BMY

Bristol-Myers Squibb Company

USD 46.68

-0.74%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 52.21

0.11%

GSK.L

GSK plc

USD 19.07

-0.64%

CSL.AX

CSL Limited

USD 157.08

1.15%

COR

Cencora, Inc.

USD 292.32

-0.61%

REGN

Regeneron Pharmaceuticals, Inc.

USD 520.29

-0.38%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 128.65

-0.79%

BDX

Becton, Dickinson and Company

USD 170.90

-0.39%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.29

-1.15%

4502.T

Takeda Pharmaceutical Company Limited

USD 30.06

0.25%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 321.94

-0.94%

StockViz Staff

June 26, 2025

Any question? Send us an email